Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

EULIR Activators

EULIR activation is intricately controlled by various signaling molecules that can augment its functional activity. Compounds such as Forskolin and Dibutyryl-cAMP target the cAMP signaling pathway, a critical regulator of numerous cellular functions, by increasing intracellular cAMP levels which in turn activate PKA. The activated PKA phosphorylates substrates that participate in the same pathway as EULIR, thus potentiating the activity of EULIR by enhancing its functional role in the cell. Similarly, activation of PKC through Phorbol 12-myristate 13-acetate (PMA) and modulation of intracellular calcium levels by calcium ionophores like Ionomycin and A23187 induces signaling events that converge on the network in which EULIR operates. These events result in the phosphorylation of kinases and other proteins that can directly or indirectly increase EULIR activity, ensuring that EULIR's functional contributions to cellular processes are enhanced.

Aside from these activators that function through phosphorylation and modulation of second messengers, there are compounds that influence EULIR activity by inhibiting competitive pathways, thereby shifting the cellular equilibrium towards EULIR activation. LY294002 and U0126, which are PI3K and MEK inhibitors respectively, reduce the activity of competing signaling routes, thus indirectly promoting the pathwaysin which EULIR is involved. This reduction in competitive signaling allows EULIR's associated pathways to become more prominent within the cell, facilitating an increase in EULIR's functional activity. Similarly, SB203580's inhibition of p38 MAPK and Epigallocatechin gallate (EGCG)'s broad-spectrum kinase inhibition affect the signaling landscape by dampening the pathways that negatively regulate EULIR function, thus indirectly enhancing EULIR's role in the cell. Furthermore, compounds like Sphingosine-1-phosphate, Thapsigargin, and Staurosporine modulate lipid signaling, calcium homeostasis, and kinase activity, respectively, which further supports the cellular mechanisms leading to EULIR activation. By intricately influencing various biochemical cascades, these chemical activators collectively ensure the upregulation of EULIR's activity without directly affecting its expression levels, demonstrating the complex interplay of cellular signaling in regulating protein function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin directly increases intracellular cAMP levels, which enhances EULIR activity by activating PKA that can phosphorylate substrates in the same pathway as EULIR.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate acts on its receptors to activate downstream MAPK signaling, which can lead to the activation of EULIR by promoting processes it is involved in.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, indirectly enhancing EULIR function by activating calcium-dependent kinases that interact with EULIR's pathway.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC) which is implicated in phosphorylation events that can enhance the activity of EULIR by modulating downstream effectors in the pathway.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP, a cAMP analog, indirectly enhances EULIR activity by activating cAMP-dependent protein kinases that can phosphorylate proteins within EULIR's signaling cascade.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, shifting the balance of signaling pathways to favor those that activate EULIR by reducing competitive signaling that can attenuate EULIR activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, which may lead to the activation of alternative pathways that enhance the role of EULIR by relieving inhibitory control mechanisms.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG inhibits multiple kinases, potentially leading to increased EULIR activity by reducing the phosphorylation of inhibitory proteins in EULIR's signaling network.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin disrupts calcium homeostasis, which can enhance EULIR activity by initiating calcium-dependent signaling cascades that interact with EULIR's functional pathways.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine broadly inhibits protein kinases, potentially leading to selective activation of pathways that enhance EULIR's role by lifting inhibition on related processes.